CPT5 - Hypertension & Heart Failure Flashcards
Overview of autonomic sympathetic activity and RAAS
Sympathetic Activity x3
Reduced Renal Blood Flow x5
Reduced GFR
Autacoids
- ) Sympathetic Activity
- a-1 –> vasoconstriction –> ↑ preload and TPR
- ß-1 in heart –> ↑HR and SV –> ↑CO
- ß-1 in kidney –> ↑renin –> activation of RAAS - ) Reduced Renal Blood Flow - ↑renin –> ↑AngII which:
- stimulates sympathetic activity
- stimulates aldosterone secretion
- stimulates NaCl/water reabsorption (+aldosterone)
- causes efferent arteriole vasoconstriction
- stimulates ADH secretion –> water reabsorption - ) Reduced GFR - caused by reduced RBF
- leads to ↑Na/water retention –> ↑BV –> ↑CO - ) Autacoids - local vasoactive hormones
- inc. bradykinin and NO
Diagnosis of hypertension
Measuring BP x3
Overcoming White Coat Hypertension x2
Diagnosing Hypertension x3
Staging Hypertension x4
- ) Measuring BP - best practice
- sitting, relaxed, and arm is supported
- use arm with higher reading
- repeat 2x if >15mmHg difference - ) Overcoming White Coat Hypertension
- ambulatory BP (ABPM) measures for 24hrs
- home monitoring (HBPM) so stress free
- patients should take BP readings a few hours after taking the medication - ) Diagnosing Hypertension - where you start treatment
- >140/90 if < 80 years (inc type II diabetes)
- >150/90 if > 80 years
- >135/85 if type 1 diabetes - ) Staging Hypertension - +20/10
- pre-hypertension: 120-140/80-90
- stage 1: >140/90, stage 2: >160/100, 3: >180/110
NICE step-wise guidelines of treating primary hypertension
4 Steps
Target Blood Pressure
- ) Step 1 - ACEi/ARB in <55 non-blacks
- if >55 or black (any age), use CCB (less renin levels)
- anyone w/ type II diabetes is given an ACEi/ARB - ) Step 2 - CCB or thiazide-like diuretics
- others are given an ACEi/ARB or thiazide-like diuretic
3.) Step 3 - ACEi/ARB + CCB + thiazide-like diuretic
- ) Step 4 - resistant hypertension
- low dose spironolactone if serum K+ is < 4.5 mM
- a/ß-blocker (carvediol, BB) if serum K+ is >4.5 mM - ) Target Blood Pressure
- <140/90 if < 80 years old
- <150/90 if >80 years old
Using ACEi and ARBs to treat hypertension
Drug Names (ACEi x2, ARBs x2) Mechanism Independent AngII Production Side Effects x6 Contraindications x5 Cautions x3
- ) Drug Names
- ACEi - lisinopril and ramipril
- ARBs - candesartan and lorsartan - ) Mechanism
- ACEi prevents formation of AngII and breakdown of bradykinin
- ARBs block AT1 receptors AngII primarily acts on - ) Independent AngII Production - chymases can produce AngII from AngI without the need for ACE
- this makes ARBs more effective - ) Side-Effects - hypotension
- dry cough and angioedema: ↑bradykinin (ACEi)
- hyperkalemia: ↓aldosterone
- renal failure in renal artery stenosis: efferent arteriole cannot constrict
- nephrotoxic - ) Contraindications
- pregnancy, breastfeeding (ARBs)
- AKI, CKD, renal artery stenosis
6.) Caution - ↑K+ drugs, NSAIDs, other anti-hypertensives
- a small rise in creatinine (<20%) is expected when starting an ACEi or ARB, the drug should be continued and measurements repeated in one week
Why ACEi/ARBs are first-line for all patients with type 2 diabetes (2 reasons)
Intraglomerular Pressure
Reduced Intraglomerular Pressure - ↓BP and dilation of efferent glomerular arteriole
- good for type II diabetes
Reduced chance of diabetic nephropathy and CKD w/ proteinuria
Using dihydropyridine CCBs to treat hypertension
Drug Names x3 Mechanism Side-Effects x4 Contraindications x2 Caution x2
1.) Drug Names - amlodipine, nifedipine, nimodipine
- ) Mechanism - prevents Ca2+ influx through VOCC
- selective for vasculature so prevents vasoconstriction
- nimodipine is selective for cerebral vasculature so is used in a subarachnoid haemorrhage - ) Side-Effects - due to vasodilation
- ankle swelling (can add diuretic if doesn’t resolve)
- flushing, headaches
- palpitations (compensatory tachycardia) - ) Contraindications
- unstable angina and severe aortic stenosis
- protein leakage (check ACR, albumin:creatinine) - ) Caution
- amlodipine + simvastatin (↑effect of statin)
- other anti-hypertensive agents
Using non-dihydropyridine CCBs to treat hypertension
Drug Names x2 Mechanism Side Effects x4 Contraindications x2 Caution x3
- ) Drug Names - verapamil and diltiazem
- verapamil is a phenylalkylamine
- diltiazem is a benzothiazapine which sits in between other CCB classes - ) Mechanism - prevents Ca2+ influx through VOCC
- selective for the heart so reduces HR and SV
- causes some coronary and peripheral vasodilation
- class IV anti-arrhythmic drug so is also used for arrhythmia and angina - ) Side-Effects
- bradycardia (IV), heart block, cardiac failure
- constipation - ) Contraindications
- poor LV function, AV nodal conduction delay
5.) Caution - beta blockers, other antihypertensive and antiarrhythmic drugs
Using thiazide/thiazide-like diuretics to treat hypertension
Drug Names x2 Mechanism Side-Effects x7 Contraindications x3 Caution x2
- ) Drug Names - bendroflumethiazide, indapamide
- bendroflumethiazide (thiazide)
- indapamide (thiazide-like) - ) Mechanism - inhibits Na-Cl symporter in DCT
- reduces Na/water retention - ) Side-Effects
- ↓K+, ↓Na+, ↑urea (hyperuricemia), ↑glucose
- ↑cholesterol (LDL) and triglycerides
- arrhythmia - ) Contraindications
- hypokalaemia, hyponatraemia, gout - ) Caution
- NSAIDs, ↓K+ drugs
Using beta-adrenoceptor blockers to treat resistant hypertension
Drug Names x3 Mechanism Gestational Hypertension Side Effects x7 Contraindications x3 Caution
- ) Drug Names
- labetalol,
- bisoprolol (cardio-selective)
- metoprolol
- carvediol - ) Mechanism - blocks ß-1 adrenoceptors
- ↓myocardial contraction –> ↓CO –> ↓renin secretion - ) Gestational Hypertension - IV labetalol
- first line treatment of hypertension in pregnancy - ) Side Effects
- heart block, cold hands, lethargy, impotence (ED)
- bronchospasm (ß-2 adrenoceptor)
- insulin resistance, ß-blockers mask the signs of hypoglycaemia (e.g. sweating, tachycardia)
5.) Contraindications
- asthma/COPD
- hepatic failure
- haemodynamic instability
- ) Caution - use of non-dihydropyridine CCBs
- can cause asystole
Using beta-adrenoceptor blockers to treat resistant hypertension
Drug Names x3 Mechanism Gestational Hypertension Side Effects x7 Contraindications x3 Caution
- ) Drug Names
- labetalol,
- bisoprolol (cardio-selective)
- metoprolol
- carvediol - ) Mechanism - blocks ß-1 adrenoceptors
- ↓myocardial contraction –> ↓CO –> ↓renin secretion - ) Gestational Hypertension - IV labetalol
- first line treatment of hypertension in pregnancy - ) Side Effects
- heart block, cold hands, lethargy, impotence
- bronchospasm (ß-2 adrenoceptor)
- insulin resistance, ß-blockers mask the signs of hypoglycaemia (e.g. sweating, tachycardia)
5.) Contraindications
- asthma/COPD (bronchospasm)
- hepatic failure, haemodynamic instability
- peripheral vascular disease e.g. ischaemic leg ulcers
- ) Caution - use of non-dihydropyridine CCBs
- can cause asystole
Using alpha-adrenoceptor blockers to treat resistant hypertension
Drug Name Mechanism Side Effects x5 Contraindication Caution
1.) Drug Name - doxazosin
- ) Mechanism - selective a-1 adrenoceptor blocker
- ↓TPR –> ↓preload –> ↓CO –> ↓renin release - ) Side Effects - postural hypotension, headache, dizziness, syncope, fatigue
- ) Contraindications - postural hypotension
- ) Caution - use of dihydropyridine CCBs
- can cause oedema
NICE step-wise guidlines of managing heart failure
First Line Treatment HFpEF HFrEF Third Line Treatment Non-Pharmacological Management
- ) First Line Treatment - diuretics (e.g furosemide)
- manages congestive symptoms and fluid retention
- furosemide (IV if severely overloaded)
- bumetanide (oral)
- bendroflumethiazide can be added - ) HFpEF (>45%)- manage co-morbidities:
- hypertension, atrial fibrillation, IHDs, diabetes - HFrEF (<45%) - medication
- ACEi OR ARB, hydralazine and isosorbide mononitrate if intolerant to both
- BB e.g. bisoprolol if BP>100 and resting HR >60 (ivabradine if contraindicated)
- sacubitril/valsartan (EF <35%) as addition to ACEi/ARB
- spironolactone if symptoms continue (↑ life expectancy in heart failure) - ) Third Line Treatment - personalised exercise-based cardiac rehabilitation program unless unstable condition
- pacemaker if LBBB (CRT or ICD) - ) Non-Pharmacological Management
- salt and fluid restriction